Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Disease; Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06664151
What this trial is testing

Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell Cancer
Dana-Farber Cancer Institute 25
Large-scale testing (Phase 3)Study completedNCT01153685
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza
GlaxoSmithKline 120
Large-scale testing (Phase 3)Study completedNCT01229397
What this trial is testing

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Who this might be right for
Influenza
Crucell Holland BV 205
Large-scale testing (Phase 3)Study completedNCT01310413
What this trial is testing

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 842
Early research (Phase 1)Study completedNCT00714285
What this trial is testing

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

Who this might be right for
Influenza
GlaxoSmithKline 420
Testing effectiveness (Phase 2)Study completedNCT01561768
What this trial is testing

Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Who this might be right for
Influenza
Novavax 500
Testing effectiveness (Phase 2)Study completedNCT05823974
What this trial is testing

Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,275
Post-approval studies (Phase 4)Looking for participantsNCT06841913
What this trial is testing

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Who this might be right for
Smoke ExposureInfluenza
University of North Carolina, Chapel Hill 112
Testing effectiveness (Phase 2)UnknownNCT06254820
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza B Strain

Who this might be right for
Influenza B
Hvivo 60
Large-scale testing (Phase 3)Study completedNCT06178991
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

Who this might be right for
InfluenzaCOVID-19
BioNTech SE 8,795
Post-approval studies (Phase 4)Study completedNCT02655874
What this trial is testing

Tropical Influenza Control Strategies for the Elderly

Who this might be right for
Influenza, Human
Tan Tock Seng Hospital 200
Post-approval studies (Phase 4)UnknownNCT03756246
What this trial is testing

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

Who this might be right for
DepressionHealthy
University of Texas at Austin 75
Post-approval studies (Phase 4)Study completedNCT03020537
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Who this might be right for
Influenza
Stanford University 8
Large-scale testing (Phase 3)Looking for participantsNCT07626437
What this trial is testing

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

Who this might be right for
Common Cold/FluNasal CongestionNasal Obstruction
Brainfarma Industria Química e Farmacêutica S/A 620
Early research (Phase 1)Study completedNCT00382980
What this trial is testing

Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 308
Post-approval studies (Phase 4)Study completedNCT00649922
What this trial is testing

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abbott 226
Testing effectiveness (Phase 2)Study completedNCT00391391
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 520
Early research (Phase 1)Study completedNCT02251288
What this trial is testing

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Who this might be right for
Avian InfluenzaImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 62
Not applicableStudy completedNCT05690373
What this trial is testing

Probiotics and Influenza Vaccination Response

Who this might be right for
Vaccine Response
The Archer-Daniels-Midland Company 100
Not applicableStudy completedNCT01431183
What this trial is testing

Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions

Who this might be right for
Seasonal Influenza Vaccination
University of Michigan 3,618
Next Page